Skip to Content
COVID-19 Response and Update
International
  • About
        • AboutWe challenge convention so healthy can be possible
        • Our Story
          • Amneal at-a-glance
          • Our Founders
          • Our Milestones
        • Our Purpose & Commitments
        • Our Culture
          • Rise, Lead, Succeed
        • Our Leadership
          • Executive Leadership
          • Board of Directors
        • Our Locations
        • Responsibility
          • The Amneal Patient Assistance Program
          • Product Donations
          • National and Local Philanthropy
          • Compliance and Ethics
        • Patient Community Connections
          • Our Commitment to Parkinson’s
        • Awards & Recognition
  • Products
        • ProductsWe create essential medicines
        • Our Portfolio
          • Biosciences
          • Generic Products
          • Specialty Products
          • Product Catalog
        • Quality
        • Drug Safety
          • Adverse Event Reporting
          • Medical Inquiries
          • Product Complaints
        • Operations
  • Research & Development
        • Research & DevelopmentWe invest significantly in new product development
        • Generics R&D
        • Specialty R&D
          • Drug Delivery Technologies
        • Product Partnering
  • Investors
        • InvestorsBecome an Informed Investor
        • Financial Reports
          • SEC Filings
          • Annual Reports
          • Quarterly & Other Reports
        • Events & Presentations
        • Stock Information
        • Corporate Governance
          • Policies
          • Executive Officers & Directors
          • Board Committees
        • Investor Resources
          • Analysts
          • Investor FAQ
          • Email Alerts
          • Information Request
          • RSS Feeds
  • News
  • Careers
        • CareersHelp make healthy possible
        • Total Rewards
        • Search Our Career Opportunities
  • Contact
  • Customer Login
Amneal Pharmaceuticals

Biosciences

Amneal’s latest innovations in access and affordability

Our Biosciences business delivers a growing portfolio of biosimilars and specialty injectable products across multiple therapeutic areas, including movement disorders and oncology. The business delivers value for patients and providers through increased choice, access, and affordability when these highly specialized and typically high-cost medicines are the appropriate option for care. Biosciences products are marketed through our deeply experienced U.S.-based Regional and Key Account Managers, who support hospitals, clinics, and specialty health care providers specializing in various therapeutic categories.

 

Biosciences Business & Products(opens in a new tab)

  • Privacy Notice
  • Copyright & Legal Disclaimer
  • Web Accessibility
  • Expanded Access Policy
  • NABP DDA Accreditation
  • Linkedin
  • Twitter
  • Youtube
© 2023 Amneal Pharmaceuticals LLC.
All rights reserved.